ArticleInternational journal of retina and vitreous2026
Evaluation of the choroidal structural and vasculature changes following COVID-19 infection and vaccination using optical coherence tomography angiography.
Article in International journal of retina and vitreous, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the impact of COVID-19 infection and various COVID-19 vaccines on choroidal structure, vasculature, and the foveal avascular zone (FAZ) using optical coherence tomography angiography (OCTA).
methodsThis prospective study included 200 participants, divided equally into five groups: 40 healthy controls, 40 individuals one month after COVID-19 infection, and three groups vaccinated with AstraZeneca, Pfizer, or Sinovac. OCTA was performed to measure choroidal thickness (CT), choriocapillaris thickness (CCT), choroidal vessel density (CVD), choriocapillaris vessel density (CC-VD), and FAZ parameters.
resultsThere were no significant differences among the five groups in central or mean CT (p = 0.246 and p = 0.053, respectively). However, significant differences were observed in both central and mean CCT (p < 0.001 and p = 0.006, respectively). Central and mean CVD also varied significantly among the groups (p = 0.004 and p = 0.035, respectively), with central CVD being significantly higher in the COVID-19 group than in the AstraZeneca and Pfizer groups (p = 0.034 and p = 0.03, respectively). Mean CC-VD differed significantly among all groups (p = 0.006), showing the highest values in the control group and the lowest in the COVID-19 group. No significant differences were found regarding FAZ area or perimeter (p = 0.174 and p = 0.334, respectively). However, FAZ circularity was significantly reduced in the COVID-19 group compared to the control and Pfizer groups (p = 0.008 and p = 0.004, respectively).
conclusionCOVID-19 infection and certain vaccine types may cause subtle but detectable changes in the choroidal microvasculature. These findings demonstrate the sensitivity of OCTA in identifying microvascular alterations in the posterior segment and enhance understanding of how different COVID-19 vaccines may influence ocular microcirculation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.